Sanofi India Limited (BOM:500674)
4,070.45
+14.85 (0.37%)
At close: Jan 23, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 93.74 billion as of January 23, 2026. Its market cap has decreased by -33.29% in one year.
Market Cap
93.74B
Enterprise Value
90.83B
Revenue
19.33B
Ranking
n/a
PE Ratio
26.31
Stock Price
4,070.45
Market Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 93.74B, an increase of 730.70%. That is a compound annual growth rate of 8.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 93.74B | -0.52% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 288.39B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 153.37B |
| Granules India | 138.61B |
| Caplin Point Laboratories | 130.85B |
| Rubicon Research | 107.10B |
| Procter & Gamble Health | 89.85B |
| Viyash Scientific | 87.71B |